[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
[HTML][HTML] Host and viral determinants of influenza A virus species specificity
…, B Mistry, SM Haslam, WS Barclay - Nature Reviews …, 2019 - nature.com
Influenza A viruses cause pandemics when they cross between species and an antigenically
novel virus acquires the ability to infect and transmit between these new hosts. The timing …
novel virus acquires the ability to infect and transmit between these new hosts. The timing …
[HTML][HTML] Cellular immune correlates of protection against symptomatic pandemic influenza
…, W Adamson, W Carman, T Bean, W Barclay… - Nature medicine, 2013 - nature.com
The role of T cells in mediating heterosubtypic protection against natural influenza illness in
humans is uncertain. The 2009 H1N1 pandemic (pH1N1) provided a unique natural …
humans is uncertain. The 2009 H1N1 pandemic (pH1N1) provided a unique natural …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
…, B Alex, P Andrikopoulos, B Bach, WS Barclay… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
…, AD Davidson, DA Matthews, WS Barclay - Nature …, 2021 - nature.com
SARS-CoV-2 entry requires sequential cleavage of the spike glycoprotein at the S1/S2 and
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion (…
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion (…
[PDF][PDF] The origins of SARS-CoV-2: A critical review
…, JO Wertheim, SJ Anthony, WS Barclay… - Cell, 2021 - cell.com
Since the first reports of a novel severe acute respiratory syndrome (SARS)-like coronavirus
in December 2019 in Wuhan, China, there has been intense interest in understanding how …
in December 2019 in Wuhan, China, there has been intense interest in understanding how …
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
P Kellam, W Barclay - Journal of General Virology, 2020 - microbiologyresearch.org
SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious disease
2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in 145 …
2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in 145 …
[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
…, PJ Openshaw, G Rapeport, WS Barclay… - Nature Medicine, 2022 - nature.com
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has caused hundreds of millions of cases and continues to circulate globally. To establish …
has caused hundreds of millions of cases and continues to circulate globally. To establish …
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA
…, S Patel, W Howard, EC Anderson, WS Barclay… - Journal of …, 2009 - Am Soc Microbiol
Influenza A virus segment 2 is known to encode two polypeptides in overlapping open reading
frames: PB1, the polymerase, and PB1-F2, a proapoptotic virulence factor. We show that …
frames: PB1, the polymerase, and PB1-F2, a proapoptotic virulence factor. We show that …
[HTML][HTML] Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a …
…, J Cutajar, V Quinn, E Conibear, W Barclay… - The lancet infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading
globally, including in populations with high vaccination rates. We aimed to investigate …
globally, including in populations with high vaccination rates. We aimed to investigate …